NDC 0074-7325

Depakote

Divalproex Sodium

Depakote is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Divalproex Sodium.

• Product ID: 0074-7325_6d3c0b68-36fe-4e32-bef0-b8bf96f8f1b9
• NDC: 0074-7325
• Product Type: Human Prescription Drug
• Proprietary Name: Depakote
• Generic Name: Divalproex Sodium
• Dosage Form: Tablet, Delayed Release
• Route of Administration: ORAL
• Marketing Start Date: 1983-03-10
• Marketing Category: NDA /
• Application Number: NDA018723
• Labeler Name: AbbVie Inc.
• Substance Name: DIVALPROEX SODIUM
• Active Ingredient Strength: 125 mg/1
• Pharm Classes: Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0074-7325-13

100 TABLET, DELAYED RELEASE in 1 BOTTLE (0074-7325-13)

• Marketing Start Date: 1983-03-10
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Depakote" or generic name "Divalproex Sodium"

NDC	Brand Name	Generic Name
0074-3826	Depakote	Divalproex Sodium
0074-6114	Depakote	Divalproex Sodium
0074-6212	Depakote	Divalproex Sodium
0074-6214	Depakote	Divalproex Sodium
0074-6215	Depakote	Divalproex Sodium
0074-7126	Depakote	Divalproex Sodium
70518-1456	Depakote	Depakote
70518-1454	Depakote	Depakote
21695-359	Depakote	Depakote
21695-163	Depakote	Depakote